Pneumococcal conjugate vaccine 15-valent - Beijing Zhifei Lvzhu Biopharmaceutical
Alternative Names: 15-valent pneumococcal conjugate vaccine; Multivalent pneumococcal conjugate vaccine - Beijing Zhifei Lvzhu Biopharmaceutical; PCV 15 - Beijing Zhifei Lvzhu BiopharmaceuticalLatest Information Update: 13 Feb 2025
Price :
$50 *
At a glance
- Originator Beijing Zhifei Lvzhu Biopharmaceutical
- Class Conjugate vaccines; Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Pneumococcal infections
Most Recent Events
- 23 Mar 2024 Beijing Zhifei Lvzhu Biopharmaceutical completes a phase-III clinical trials in Pneumococcal infections (Prevention, In infants) in China (IM) (NCT06817187)
- 28 Jul 2023 No recent reports of development identified for phase-I development in Pneumococcal-infections(In adolescents, In children, In the elderly, In infants, Prevention, In adults) in China (IM)
- 01 Jul 2023 Beijing Zhifei Lvzhu Biopharmaceutical initiates a clinical trial(In infants, In children, Prevention) in China (Parenteral, Injection) (NCT05939219)